(CVGW) Calavo Growers - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US1282461052
Stock: Avocados, Guacamole, Tomatoes, Papayas, Prepared Produce
Total Rating 44
Risk 97
Buy Signal -0.55
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.26% |
| Yield on Cost 5y | 1.16% |
| Yield CAGR 5y | -8.67% |
| Payout Consistency | 96.2% |
| Payout Ratio | 64.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 38.1% |
| Relative Tail Risk | -15.7% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.46 |
| Alpha | 9.38 |
| Character TTM | |
|---|---|
| Beta | 0.240 |
| Beta Downside | 0.122 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.81% |
| CAGR/Max DD | -0.10 |
Description: CVGW Calavo Growers December 27, 2025
Calavo Growers, Inc. (NASDAQ:CVGW) is a U.S.-based distributor of fresh and prepared avocados, as well as other perishable items such as tomatoes and papayas. It serves retail grocery, food-service, club stores, mass merchandisers, food distributors, and wholesale customers worldwide through two operating segments: Grown (raw fruit) and Prepared (guacamole, avocado pulp, etc.). The company markets its products under the Calavo brand and a suite of sub-brands (e.g., Avo Fresco, Bueno, Calavo Gold), and has been operating since 1924 from its headquarters in Santa Paula, California.
Key industry drivers that affect Calavo’s outlook include: (1) avocado consumption in the U.S. has grown at roughly 6-8% CAGR over the past decade, boosting volume demand; (2) supply-side risk from weather events in Mexico-the world’s largest avocado producer-creates price volatility and can compress margins; and (3) input cost pressure from labor and transportation, which together account for about 30-35% of Calavo’s cost of goods sold, making efficiency gains in its Grown and Prepared segments critical for profitability.
For a deeper, data-driven valuation perspective, consider reviewing Calavo’s metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 19.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -0.51 > 1.0 |
| NWC/Revenue: 13.72% < 20% (prev 12.91%; Δ 0.81% < -1%) |
| CFO/TA 0.07 > 3% & CFO 21.5m > Net Income 19.8m |
| Net Debt (-38.6m) to EBITDA (33.1m): -1.16 < 3 |
| Current Ratio: 2.47 > 1.5 & < 3 |
| Outstanding Shares: last quarter (17.9m) vs 12m ago 0.19% < -2% |
| Gross Margin: 9.82% > 18% (prev 0.10%; Δ 971.5% > 0.5%) |
| Asset Turnover: 218.6% > 50% (prev 219.7%; Δ -1.13% > 0%) |
| Interest Coverage Ratio: 31.02 > 6 (EBITDA TTM 33.1m / Interest Expense TTM 827.0k) |
Altman Z'' 3.24
| A: 0.30 (Total Current Assets 149.4m - Total Current Liabilities 60.5m) / Total Assets 292.2m |
| B: 0.10 (Retained Earnings 27.8m / Total Assets 292.2m) |
| C: 0.09 (EBIT TTM 25.7m / Avg Total Assets 296.7m) |
| D: 0.33 (Book Value of Equity 27.9m / Total Liabilities 83.7m) |
| Altman-Z'' Score: 3.24 = A |
Beneish M -3.13
| DSRI: 0.75 (Receivables 31.6m/42.8m, Revenue 648.4m/661.5m) |
| GMI: 1.04 (GM 9.82% / 10.25%) |
| AQI: 1.13 (AQ_t 0.26 / AQ_t-1 0.23) |
| SGI: 0.98 (Revenue 648.4m / 661.5m) |
| TATA: -0.01 (NI 19.8m - CFO 21.5m) / TA 292.2m) |
| Beneish M-Score: -3.13 (Cap -4..+1) = AA |
What is the price of CVGW shares?
As of February 07, 2026, the stock is trading at USD 25.43 with a total of 272,168 shares traded.
Over the past week, the price has changed by -0.04%, over one month by +19.58%, over three months by +17.77% and over the past year by +15.74%.
Over the past week, the price has changed by -0.04%, over one month by +19.58%, over three months by +17.77% and over the past year by +15.74%.
Is CVGW a buy, sell or hold?
Calavo Growers has received a consensus analysts rating of 5.00.
Therefore, it is recommended to buy CVGW.
- StrongBuy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CVGW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 27 | 6.2% |
| Analysts Target Price | 27 | 6.2% |
| ValueRay Target Price | 27.3 | 7.2% |
CVGW Fundamental Data Overview February 02, 2026
P/E Trailing = 22.9189
P/E Forward = 18.3486
P/S = 0.7013
P/B = 2.1982
P/EG = 1.66
Revenue TTM = 648.4m USD
EBIT TTM = 25.7m USD
EBITDA TTM = 33.1m USD
Long Term Debt = 23.5m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 3.57m USD (from shortTermDebt, last quarter)
Debt = 22.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -38.6m USD (from netDebt column, last quarter)
Enterprise Value = 416.1m USD (454.7m + Debt 22.6m - CCE 61.2m)
Interest Coverage Ratio = 31.02 (Ebit TTM 25.7m / Interest Expense TTM 827.0k)
EV/FCF = 21.46x (Enterprise Value 416.1m / FCF TTM 19.4m)
FCF Yield = 4.66% (FCF TTM 19.4m / Enterprise Value 416.1m)
FCF Margin = 2.99% (FCF TTM 19.4m / Revenue TTM 648.4m)
Net Margin = 3.05% (Net Income TTM 19.8m / Revenue TTM 648.4m)
Gross Margin = 9.82% ((Revenue TTM 648.4m - Cost of Revenue TTM 584.8m) / Revenue TTM)
Gross Margin QoQ = 9.34% (prev 10.18%)
Tobins Q-Ratio = 1.42 (Enterprise Value 416.1m / Total Assets 292.2m)
Interest Expense / Debt = 0.93% (Interest Expense 211.0k / Debt 22.6m)
Taxrate = 18.87% (4.65m / 24.6m)
NOPAT = 20.8m (EBIT 25.7m * (1 - 18.87%))
Current Ratio = 2.47 (Total Current Assets 149.4m / Total Current Liabilities 60.5m)
Debt / Equity = 0.11 (Debt 22.6m / totalStockholderEquity, last quarter 206.9m)
Debt / EBITDA = -1.16 (Net Debt -38.6m / EBITDA 33.1m)
Debt / FCF = -1.99 (Net Debt -38.6m / FCF TTM 19.4m)
Total Stockholder Equity = 204.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.67% (Net Income 19.8m / Total Assets 292.2m)
RoE = 9.66% (Net Income TTM 19.8m / Total Stockholder Equity 204.9m)
RoCE = 11.23% (EBIT 25.7m / Capital Employed (Equity 204.9m + L.T.Debt 23.5m))
RoIC = 10.16% (NOPAT 20.8m / Invested Capital 204.9m)
WACC = 6.51% (E(454.7m)/V(477.3m) * Re(6.80%) + D(22.6m)/V(477.3m) * Rd(0.93%) * (1-Tc(0.19)))
Discount Rate = 6.80% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 0.37%
[DCF Debug] Terminal Value 77.51% ; FCFF base≈20.2m ; Y1≈13.3m ; Y5≈6.06m
Fair Price DCF = 11.25 (EV 162.5m - Net Debt -38.6m = Equity 201.0m / Shares 17.9m; r=6.51% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 19.90 | EPS CAGR: -16.06% | SUE: -1.23 | # QB: 0
Revenue Correlation: -61.81 | Revenue CAGR: -18.95% | SUE: -1.64 | # QB: 0
EPS next Quarter (2026-04-30): EPS=0.39 | Chg30d=-0.070 | Revisions Net=+0 | Analysts=2
EPS current Year (2026-10-31): EPS=1.55 | Chg30d=-0.270 | Revisions Net=+0 | Growth EPS=-4.3% | Growth Revenue=+1.5%
EPS next Year (2027-10-31): EPS=1.60 | Chg30d=N/A | Revisions Net=+0 | Growth EPS=+3.2% | Growth Revenue=+11.2%
P/E Forward = 18.3486
P/S = 0.7013
P/B = 2.1982
P/EG = 1.66
Revenue TTM = 648.4m USD
EBIT TTM = 25.7m USD
EBITDA TTM = 33.1m USD
Long Term Debt = 23.5m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 3.57m USD (from shortTermDebt, last quarter)
Debt = 22.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -38.6m USD (from netDebt column, last quarter)
Enterprise Value = 416.1m USD (454.7m + Debt 22.6m - CCE 61.2m)
Interest Coverage Ratio = 31.02 (Ebit TTM 25.7m / Interest Expense TTM 827.0k)
EV/FCF = 21.46x (Enterprise Value 416.1m / FCF TTM 19.4m)
FCF Yield = 4.66% (FCF TTM 19.4m / Enterprise Value 416.1m)
FCF Margin = 2.99% (FCF TTM 19.4m / Revenue TTM 648.4m)
Net Margin = 3.05% (Net Income TTM 19.8m / Revenue TTM 648.4m)
Gross Margin = 9.82% ((Revenue TTM 648.4m - Cost of Revenue TTM 584.8m) / Revenue TTM)
Gross Margin QoQ = 9.34% (prev 10.18%)
Tobins Q-Ratio = 1.42 (Enterprise Value 416.1m / Total Assets 292.2m)
Interest Expense / Debt = 0.93% (Interest Expense 211.0k / Debt 22.6m)
Taxrate = 18.87% (4.65m / 24.6m)
NOPAT = 20.8m (EBIT 25.7m * (1 - 18.87%))
Current Ratio = 2.47 (Total Current Assets 149.4m / Total Current Liabilities 60.5m)
Debt / Equity = 0.11 (Debt 22.6m / totalStockholderEquity, last quarter 206.9m)
Debt / EBITDA = -1.16 (Net Debt -38.6m / EBITDA 33.1m)
Debt / FCF = -1.99 (Net Debt -38.6m / FCF TTM 19.4m)
Total Stockholder Equity = 204.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.67% (Net Income 19.8m / Total Assets 292.2m)
RoE = 9.66% (Net Income TTM 19.8m / Total Stockholder Equity 204.9m)
RoCE = 11.23% (EBIT 25.7m / Capital Employed (Equity 204.9m + L.T.Debt 23.5m))
RoIC = 10.16% (NOPAT 20.8m / Invested Capital 204.9m)
WACC = 6.51% (E(454.7m)/V(477.3m) * Re(6.80%) + D(22.6m)/V(477.3m) * Rd(0.93%) * (1-Tc(0.19)))
Discount Rate = 6.80% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 0.37%
[DCF Debug] Terminal Value 77.51% ; FCFF base≈20.2m ; Y1≈13.3m ; Y5≈6.06m
Fair Price DCF = 11.25 (EV 162.5m - Net Debt -38.6m = Equity 201.0m / Shares 17.9m; r=6.51% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 19.90 | EPS CAGR: -16.06% | SUE: -1.23 | # QB: 0
Revenue Correlation: -61.81 | Revenue CAGR: -18.95% | SUE: -1.64 | # QB: 0
EPS next Quarter (2026-04-30): EPS=0.39 | Chg30d=-0.070 | Revisions Net=+0 | Analysts=2
EPS current Year (2026-10-31): EPS=1.55 | Chg30d=-0.270 | Revisions Net=+0 | Growth EPS=-4.3% | Growth Revenue=+1.5%
EPS next Year (2027-10-31): EPS=1.60 | Chg30d=N/A | Revisions Net=+0 | Growth EPS=+3.2% | Growth Revenue=+11.2%